NASDAQ:LMAT LeMaitre Vascular (LMAT) Stock Price, News & Analysis $85.83 -0.41 (-0.48%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$84.94▼$87.5550-Day Range$77.42▼$90.3452-Week Range$44.27▼$91.76Volume138,204 shsAverage Volume124,699 shsMarket Capitalization$1.93 billionP/E Ratio56.84Dividend Yield0.75%Price Target$77.57 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get LeMaitre Vascular alerts: Email Address LeMaitre Vascular MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.89 Rating ScoreUpside/Downside9.6% Downside$77.57 Price TargetShort InterestHealthy3.91% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainabilityN/ANews Sentiment0.74Based on 6 Articles This WeekInsider TradingSelling Shares$10.08 M Sold Last QuarterProj. Earnings Growth11.30%From $1.77 to $1.97 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.31 out of 5 starsMedical Sector344th out of 936 stocksSurgical & Medical Instruments Industry44th out of 101 stocks 1.4 Analyst's Opinion Consensus RatingLeMaitre Vascular has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 6 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageLeMaitre Vascular has only been the subject of 4 research reports in the past 90 days.Read more about LeMaitre Vascular's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.91% of the float of LeMaitre Vascular has been sold short.Short Interest Ratio / Days to CoverLeMaitre Vascular has a short interest ratio ("days to cover") of 5.9.Change versus previous monthShort interest in LeMaitre Vascular has recently decreased by 0.04%, indicating that investor sentiment is improving. Previous Next 3.3 Dividend Strength Dividend YieldLeMaitre Vascular has a dividend yield of 0.71%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthLeMaitre Vascular has been increasing its dividend for 13 years.Dividend CoverageThe dividend payout ratio of LeMaitre Vascular is 42.38%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, LeMaitre Vascular will have a dividend payout ratio of 32.49% next year. This indicates that LeMaitre Vascular will be able to sustain or increase its dividend.Read more about LeMaitre Vascular's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for LMAT. Previous Next 2.6 News and Social Media Coverage News SentimentLeMaitre Vascular has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for LeMaitre Vascular this week, compared to 3 articles on an average week.Search InterestOnly 1 people have searched for LMAT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added LeMaitre Vascular to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, LeMaitre Vascular insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,076,242.00 in company stock.Percentage Held by Insiders10.79% of the stock of LeMaitre Vascular is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions84.64% of the stock of LeMaitre Vascular is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LeMaitre Vascular's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for LeMaitre Vascular are expected to grow by 11.30% in the coming year, from $1.77 to $1.97 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LeMaitre Vascular is 56.84, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.95.Price to Earnings Ratio vs. SectorThe P/E ratio of LeMaitre Vascular is 56.84, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 150.64.Price to Earnings Growth RatioLeMaitre Vascular has a PEG Ratio of 2.75. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioLeMaitre Vascular has a P/B Ratio of 6.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about LeMaitre Vascular's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. About LeMaitre Vascular Stock (NASDAQ:LMAT)LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.Read More LMAT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LMAT Stock News HeadlinesJuly 17, 2024 | insidertrades.comInsider Selling: LeMaitre Vascular, Inc. (NASDAQ:LMAT) CEO Sells 12,976 Shares of StockJuly 26 at 7:32 AM | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Downgraded to Hold at StockNews.comJuly 26, 2024 | Porter & Company (Ad)We recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…July 19, 2024 | americanbankingnews.comLeMaitre Vascular (NASDAQ:LMAT) Raised to "Buy" at StockNews.comJuly 18, 2024 | americanbankingnews.comGeorge W. Lemaitre Sells 12,976 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockJuly 18, 2024 | americanbankingnews.comGeorge W. Lemaitre Sells 27,030 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) StockJuly 16, 2024 | globenewswire.comLeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024June 30, 2024 | seekingalpha.comLeMaitre: Further Upsides Supported By Longer Competitive Advantage PeriodJuly 26, 2024 | Porter & Company (Ad)We recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…May 22, 2024 | money.usnews.comLemaitre Vascular IncMay 21, 2024 | globenewswire.comLeMaitre to Present at the Jefferies Global Healthcare ConferenceMay 11, 2024 | finance.yahoo.comWhy You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming DividendMay 5, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their PredictionsMay 4, 2024 | finance.yahoo.comLeMaitre Vascular First Quarter 2024 Earnings: Beats ExpectationsMay 4, 2024 | finanznachrichten.deLeMaitre Vascular, Inc.: LeMaitre Q1 2024 Financial ResultsMay 3, 2024 | markets.businessinsider.comKeyBanc Keeps Their Hold Rating on Lemaitre Vascular (LMAT)May 3, 2024 | markets.businessinsider.comOppenheimer Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)May 3, 2024 | finance.yahoo.comLeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call TranscriptSee More Headlines Receive LMAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LeMaitre Vascular and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Ex-Dividend for 5/30 Dividend5/15/2024Dividend Payable5/30/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:LMAT CUSIPN/A CIK1158895 Webwww.lemaitre.com Phone(781) 221-2266Fax781-425-5049Employees614Year Founded1983Price Target and Rating Average Stock Price Target$77.57 High Stock Price Target$100.00 Low Stock Price Target$67.00 Potential Upside/Downside-9.6%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)$1.51 Trailing P/E Ratio56.84 Forward P/E Ratio48.49 P/E Growth2.75Net Income$30.10 million Net Margins16.99% Pretax Margin22.14% Return on Equity11.57% Return on Assets10.02% Debt Debt-to-Equity RatioN/A Current Ratio7.57 Quick Ratio5.31 Sales & Book Value Annual Sales$193.48 million Price / Sales9.96 Cash Flow$1.70 per share Price / Cash Flow50.59 Book Value$13.38 per share Price / Book6.41Miscellaneous Outstanding Shares22,450,000Free Float20,024,000Market Cap$1.93 billion OptionableOptionable Beta0.89 Social Links 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. George W. LeMaitre (Age 59)Chairman & CEO Comp: $1.12MMr. David B. Roberts (Age 60)President & Director Comp: $634.85kMr. Joseph P. Pellegrino Jr. (Age 59)CFO, Secretary & Director Comp: $566.19kMr. Trent G. Kamke (Age 53)Senior Vice President of Operations Comp: $445.38kDr. George D. LeMaitre (Age 90)Founder and Chairman of Scientific Advisory Board Comp: $118.48kMr. David C. Hissong (Age 54)VP & General Counsel Ms. Kimberly L. Cieslak (Age 51)Vice President of Marketing Mr. Daniel J. Mumford (Age 42)Senior Director of Human Resources Mr. Maik D. Helmers (Age 50)Senior Vice President of Sales Central Europe Mr. Ryan H. Connelly (Age 47)Senior Vice President of Advanced Manufacturing Engineering More ExecutivesKey CompetitorsCardiovascular SystemsNASDAQ:CSIICryoLifeNYSE:CRYVapothermNYSE:VAPOPenumbraNYSE:PENGlaukosNYSE:GKOSView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 5,213 shares on 7/26/2024Ownership: 0.938%Legato Capital Management LLCBought 6,028 shares on 7/26/2024Ownership: 0.113%Shaker Investments LLC OHBought 175 shares on 7/26/2024Ownership: 0.062%Allspring Global Investments Holdings LLCBought 3,498 shares on 7/26/2024Ownership: 0.041%Louisiana State Employees Retirement SystemBought 300 shares on 7/24/2024Ownership: 0.045%View All Insider TransactionsView All Institutional Transactions LMAT Stock Analysis - Frequently Asked Questions How have LMAT shares performed this year? LeMaitre Vascular's stock was trading at $56.76 at the beginning of 2024. Since then, LMAT shares have increased by 51.2% and is now trading at $85.83. View the best growth stocks for 2024 here. How were LeMaitre Vascular's earnings last quarter? LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced its quarterly earnings data on Thursday, May, 2nd. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.39 by $0.05. LeMaitre Vascular's revenue was up 13.6% compared to the same quarter last year. What is George W. LeMaitre's approval rating as LeMaitre Vascular's CEO? 13 employees have rated LeMaitre Vascular Chief Executive Officer George W. LeMaitre on Glassdoor.com. George W. LeMaitre has an approval rating of 33% among the company's employees. This puts George W. LeMaitre in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. Does LeMaitre Vascular have any subsidiaries? The following companies are subsidiaries of LeMaitre Vascular: Artegraft, CardioCel, Tru-Incise (Eze-Sit) US, VascuCel, LeMaitre Cardial SAS, Syntel and Python, ProCol, and more. Who are LeMaitre Vascular's major shareholders? LeMaitre Vascular's top institutional shareholders include Bank of New York Mellon Corp (0.94%), Chatham Capital Group Inc. (0.22%), Linden Thomas Advisory Services LLC (0.14%) and Raymond James & Associates (0.13%). Insiders that own company stock include George W Lemaitre, David B Roberts, Joseph P Pellegrino Jr, Trent G Kamke, Bridget A Ross and John A Roush. View institutional ownership trends. How do I buy shares of LeMaitre Vascular? Shares of LMAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of LeMaitre Vascular own? Based on aggregate information from My MarketBeat watchlists, some other companies that LeMaitre Vascular investors own include AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACBFF) and NVIDIA (NVDA). This page (NASDAQ:LMAT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
